Sami A. Gabr
About
In The Last Decade
Sami A. Gabr
72 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 127
- Physiology 245
- Molecular Biology 192
- Public Health, Environmental and Occupational Health 169
- Epidemiology 131
- Pathology and Forensic Medicine 122
Countries citing papers authored by Sami A. Gabr
This map shows the geographic impact of Sami A. Gabr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sami A. Gabr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sami A. Gabr more than expected).
Fields of papers citing papers by Sami A. Gabr
This network shows the impact of papers produced by Sami A. Gabr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sami A. Gabr. The network helps show where Sami A. Gabr may publish in the future.
Co-authorship network of co-authors of Sami A. Gabr
This figure shows the co-authorship network connecting the top 25 collaborators of Sami A. Gabr. A scholar is included among the top collaborators of Sami A. Gabr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sami A. Gabr. Sami A. Gabr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 10 | |
| 3 | 2 | |
| 4 | 8 | |
| 5 | 16 | |
| 6 | 16 | |
| 7 | 4 | |
| 8 | 5 | |
| 9 | 18 | |
| 10 | 6 | |
| 11 | 10 | |
| 12 | 12 | |
| 13 | 21 | |
| 14 | 8 | |
| 15 | 18 | |
| 16 | 37 | |
| 17 | 12 | |
| 18 | 50 | |
| 19 | Bcl-2 and p53 expression in hepatic tissues of Egyptian patients with Chronic Hepatitis C. | 4 |
| 20 | Structure and quantitative structure-activity relationship (QSAR) for (±) 3, 5-diphenyl-2-thioxoimidazolidin-4-ones as prominent cyclooxygenase-2 inhibitors | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.